Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.75.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAKNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.50NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.494NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.167NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.267NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.165NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.554NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.243.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.5.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.450NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.130NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.444NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
AW.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.268NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.344NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.103NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.119NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.276NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.111NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.336NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.400.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.537NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.548NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.24.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.492NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.540NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.118NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XATNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.85NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.65NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.62NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used